Effects of hyperbaric oxygen therapy on NACHT domain-leucine-rich-repeat- and pyrin domain-containing protein 3 inflammasome expression in rats following spinal cord injury

Liang,Fang; Li,Chunsheng; Gao,Chunjin; Li,Zhuo; Yang,Jing; Liu,Xuehua; Wang,Yong

doi:10.3892/mmr.2015.3314

Effects of hyperbaric oxygen therapy on NACHT domain-leucine-rich-repeat- and pyrin domain-containing protein 3 inflammasome expression in rats following spinal cord injury

Authors:
- Fang Liang
- Chunsheng Li
- Chunjin Gao
- Zhuo Li
- Jing Yang
- Xuehua Liu
- Yong Wang
View Affiliations

Affiliations: Department of Hyperbaric Oxygen, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, P.R. China, Department of Emergency, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, P.R. China, Department of Hyperbaric Oxygen, Beijing Fuxing Hospital, Capital Medical University, Beijing 100020, P.R. China
Published online on: February 6, 2015 https://doi.org/10.3892/mmr.2015.3314
Pages: 4650-4656

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The clinical application of hyperbaric oxygen therapy (HBOT) in spinal cord injury (SCI) has been reported, however the mechanism underlying its therapeutic effects remains to be elucidated. In the present study, SCI was modeled in male Sprague‑Dawley rats. A total of 120 rats were randomly divided into four groups: Sham‑operated group (SH); sham‑operated and hyperbaric oxygen group (SH+HBO); spinal cord injury group (SCI) and spinal cord injury and hyperbaric oxygen treatment group (SCI+HBO). The rats in each group were randomly divided into five smaller groups (12 h, 1, 3, 7 and 14 days after surgery). The mRNA and protein expression levels of NACHT domain‑, leucine‑rich‑repeat‑ and pyrin domain‑containing protein 3 (NALP3) inflammasome, including NALP3, adaptor molecule apoptosis‑associated speck‑like protein (ASC) and caspase‑1 were determined at several time points following injury. The results of the present study demonstrated that HBOT compromised the mRNA and protein expression levels of NALP3, ASC and caspase‑1 in the SCI model rats and HBOT mitigated SCI‑induced interleukin 1β release in the injured spinal cord tissue. It was concluded that HBOT is an effective approach, which can prevent against spinal cord injury, likely by inactivating NALP3 inflammasome.

View Figures

View References

1	Dumont RJ, Okonkwo DO, Verma S, Hurlbert RJ, Boulos PT, Ellegala DB and Dumont AS: Acute spinal cord injury, part I: Pathophysiologic mechanisms. Clin Neuropharmacol. 24:254–264. 2001. View Article : Google Scholar : PubMed/NCBI
2	Kwon BK, Tetzlaff W, Grauer JN, Beiner J and Vaccaro AR: Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J. 4:451–464. 2004. View Article : Google Scholar : PubMed/NCBI
3	Hall ED and Springer JE: Neuroprotection and acute spinal cord injury: a reappraisal. NeuroRx. 1. pp. 80–100. 2004, View Article : Google Scholar
4	Beck KD, Nguyen HX, Galvan MD, Salazar DL, Woodruff TM and Anderson AJ: Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain. 133. pp. 433–447. 2010, View Article : Google Scholar
5	Duz B, Kaplan M, Bilgic S, et al: Does hypothermic treatment provide an advantage after spinal cord injury until surgery? An experimental study. Neurochem Res. 34:407–410. 2009. View Article : Google Scholar
6	Diaz-Ruiza A, Maldonadoc PD, Mendez-Armenta M, et al: Activation of heme oxygenase recovers motor function after spinal cord injury in rats. Neurosci Lett. 556:26–31. 2013. View Article : Google Scholar
7	Maggio DM, Chatzipanteli K, Masters N, Patel SP, Dietrich WD and Pearse DD: Acute molecular perturbation of inducible nitric oxide synthase with an antisense approach enhances neuronal preservation and functional recovery after contusive spinal cord injury. J Neurotrauma. 29:2244–2249. 2012. View Article : Google Scholar : PubMed/NCBI
8	Kubeck JP, Merola A, Mathur S, et al: End organ effects of high-dose human equivalent methylpredniso-lone in a spinal cord injury rat model. Spine. 31:257–261. 2006. View Article : Google Scholar
9	Kahraman S, Düz B, Kayali H, et al: Effects of methylprednisolone and hyperbaric oxygen on oxidative status after experimental spinal cord injury: a comparative study in rats. Neurochem Res. 32:1547–1551. 2007. View Article : Google Scholar : PubMed/NCBI
10	Gamache FW Jr, Myers RA, Ducker TB, et al: The clinical application of hyperbaric oxygen therapy in spinal cord injury: a preliminary report. Surg Neurol. 15:85–87. 1981. View Article : Google Scholar : PubMed/NCBI
11	Kindwall EP, Gottlieb LJ and Larson DL: Hyperbaric oxygen therapy in plasticsurgery: a review article. Plast Reconstr Surg. 88:898–908. 1991. View Article : Google Scholar : PubMed/NCBI
12	Petrilli V, Dostert C, Muruve DA, et al: The inflammasome: a danger sensing complex triggering innate immunity. Current Opin Immunol. 19:615–622. 2007. View Article : Google Scholar
13	Lamkanfi M and Dixit M: Inflammasomes: guardians of cytosolic sanctity. Immunol Rev. 227:95–105. 2009. View Article : Google Scholar : PubMed/NCBI
14	Villegas LR, Field C, Kluck D, et al: Superoxide dismutase mimetic attenuates hypoxia-induced pulmonary vascular remodeling, ECM hyaluronan expression, and NALP3-mediated inflammation. Free Radical Bio Med. 10:3642011.
15	Basso DM, Beattie MS and Bresnahan JC: Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight drop device versus transaction. Exp Neurol. 139. pp. 244–256. 1996, View Article : Google Scholar
16	Martinon F and Tschopp J: NLRs join TLRs as innate sensors of pathogens. Trends Immunol. 26:447–454. 2005. View Article : Google Scholar : PubMed/NCBI
17	Aqostin L, Martinon F, Burns K, et al: NALP3 forms an L-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity. 20:319–325. 2004. View Article : Google Scholar
18	Chen M, Wang H, Chen W, et al: Regulation of adaptive immunity by the NLRP3 inflammasome. Int Immunopharmacol. 11:549–555. 2011. View Article : Google Scholar
19	Bao F, Dekaban GA and Weaver LC: Anti-CD11d antibody treatment reduces free radical formation and cell death in the injured spinal cord of rats. J Neurochem. 94:1361–1373. 2005. View Article : Google Scholar : PubMed/NCBI
20	Hachmeister JE, Valluru L, Bao F and Liu D: Mn (III) tetrakis (4-benzoic acid) porphyrin administered into the intrathecal space reduces oxidative damage and neuron death after spinal cord injury: a comparison with methylprednisolone. J Neurotrauma. 23:1766–1778. 2006. View Article : Google Scholar : PubMed/NCBI
21	Allen IC, Scull MA, Moore CB, et al: The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity. 30:556–565. 2009. View Article : Google Scholar : PubMed/NCBI
22	Kauppinen A, Niskanen H, Suuronen T, Kinnunen K, Salminen A and Kaarniranta K: Oxidative stress activates NLRP3 inflammasomes in ARPE-19 cells - implications for age-related macular degeneration (AMD). Immunol Lett. 147:29–33. 2012. View Article : Google Scholar : PubMed/NCBI
23	Juliana C, Fernandes-Alnemri T, Kang S, Farias A, Qin F and Alnemri ES: Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation. J Biol Chem. 287:36617–36622. 2012. View Article : Google Scholar : PubMed/NCBI
24	Menu P and Vince JE: The NLRP3 inflammasome in health and disease: the good, the bad and the ugly. Clin Exp Immunol. 166:1–15. 2011. View Article : Google Scholar : PubMed/NCBI
25	Lawlor KE and Vince JE: Ambiguities in NLRP3 in flammasome regulation: is there a role for mitochondria? Biochim Biophys Acta. 10:08–14. 2013.
26	Vince IE, Wong WW, Gentle I, et al: Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. Immunity. 36:215–227. 2012. View Article : Google Scholar : PubMed/NCBI
27	Yaman O, Yaman B, Aydin F, Var A and Temiz C: Hyperbaric oxygen treatment in the experimental spinal cord injury model. Spine J. 14:2184–2194. 2014. View Article : Google Scholar : PubMed/NCBI
28	Ishihara H, Kanamori M, Kawaguchi Y, Osada R, Ohmori K and Matsui H: Prediction of neurologic outcome in patients with spinal cord injury by using hyperbaric oxygen therapy. J Orthop Sci. 6:385–389. 2001. View Article : Google Scholar
29	Topuz K, Colak A, Cemil B, et al: Combined hyperbaric oxygen and hypothermia treatment on oxidative stress parameters after spinal cord injury: an experimental study. Arch Med Res. 41:506–512. 2010. View Article : Google Scholar : PubMed/NCBI
30	Yu Y, Matsuyama Y, Yanase M, et al: Effects of hyperbaric oxygen on GDNF expression and apoptosis in spinal cord injury. Neuroreport. 15:2369–2373. 2004. View Article : Google Scholar
31	Rubartelli A: Redox control of NLRP3 inflammasome activation in health and disease. J Leukoc Biol. 92:951–958. 2012. View Article : Google Scholar : PubMed/NCBI
32	Liu S, Xu GY, Johnson KM, et al: Regulation of interleukin-1beta by the interleukin-1 receptor antagonist in the glutamate-injured spinal cord: endogenous neuroprotection. Brain Res. 1231:63–74. 2008. View Article : Google Scholar : PubMed/NCBI
33	Sung CS, Wen ZH, Chang WK, et al: Intrathecal interleukin-1beta administration induces thermal hyperalgesia by activating inducible nitric oxide synthase expression in the rat spinal cord. Brain Res. 1015:145–153. 2004. View Article : Google Scholar : PubMed/NCBI
34	Martinon F, Burns K and Tschopp J: The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of pro IL-beta. Mol Cell. 10:417–426. 2002. View Article : Google Scholar : PubMed/NCBI
35	Kool M, Pétrilli V, De Smedt T, et al: Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J Immunol. 181:3755–3759. 2008. View Article : Google Scholar : PubMed/NCBI
36	Yang J, Liu X, Zhou Y, Wang G, Gao C and Su Q: Hyperbaric oxygen alleviates experimental (spinal cord) injury by downregulating HMGB1/NF-κB expression. Spine. 38:1641–1648. 2013. View Article : Google Scholar